ARTICLE | Company News
Immunomedics other research news
August 2, 1993 7:00 AM UTC
IMMU received a $50,000 Phase I SBIR grant from the National Cancer Institute to develop cancer imaging agents using bivalent F(ab')2 antibody fragments, which may allow better imaging in the area of ...